SHERI BECK: Open Payments
NPI 1285053116 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 20 payments from 11 companies in 2025. Trend: 2023 $438 · 2024 $1,064 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $122 |
| PFIZER INC. | 3 | $74 |
| Amgen Inc. | 4 | $59 |
| Exact Sciences Corporation | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| SANOFI PASTEUR INC. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Tempus AI, Inc | 1 | $17 |
| Abbott Laboratories | 1 | $17 |
Products named: AREXVY, Cologuard Collection Kit, PREVNAR 20, OTEZLA, GARDASIL 9, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, FARXIGA, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
